190964-91-1

Basic information

• Product Name: tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate
• Synonyms: 1-Piperidinecarboxylic acid, 4-(4-Methyl-1-piperazinyl)-, 1,1-diMethylethyl ester;tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate;4-(4-Methyl-1-piperazinyl)-1-piperidinecarboxylic acid tert-butyl ester
• CAS NO: 190964-91-1
• Molecular Formula: C15H29N3O2
• Molecular Weight: 283.41
• Mol File: 190964-91-1.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 370.2 °C at 760 mmHg
• Flash Point: 177.7 °C
• Appearance: /
• Density: 1.061
• CAS DataBase Reference: tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate(190964-91-1)
• EPA Substance Registry System: tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate(190964-91-1)

Safety Data

• Hazardous Substances Data: 190964-91-1(Hazardous Substances Data)

Usage

Description

Tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate is a chemical compound that features a piperidine ring with a tert-butyl and a methylpiperazine group attached to it. tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate is known for its steric hindrance due to the tert-butyl group, which makes the molecule more rigid and less susceptible to degradation. The presence of the piperazine ring in the molecule is significant as it contributes to its biological activity, with piperazine derivatives being recognized for their diverse pharmacological properties. tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate is also valuable in research and development, serving as a building block for the creation of new chemical entities with potential therapeutic applications.

Uses

Used in Pharmaceutical Synthesis:
Tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate is used as a precursor in the synthesis of pharmaceutical drugs, leveraging its structural features to contribute to the development of new medications.
Used in Organic Chemistry:
In the field of organic chemistry, tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate is used as a building block for the creation of new chemical entities, potentially leading to the discovery of novel compounds with therapeutic applications.
Used in Research and Development:
Tert-butyl 4-(4-methylpiperazin-1-yl)piperidine-1-carboxylate is employed in research settings to explore its potential as a component in the design of new molecules with biological activity, particularly in the context of drug discovery and development.

Upstream product

• 109-01-3 1-methyl-piperazine 
• 3612-20-2 1-phenylmethyl-4-piperidone 
• 24424-99-5 di-tert-butyl dicarbonate 
• 79099-07-3 N-tert-butyloxycarbonylpiperidin-4-one 

Downstream Products

• 1219979-73-3 1-methyl-4-(piperidin-4-yl)piperazine monohydrochloride 

Relevant articles and documents

ARYL-PHOSPHORUS-OXYGEN COMPOUND AS EGFR KINASE INHIBITOR

Disclosed is a class of new aryl-phosphorus-oxygen compounds as shown in formula (I) as EGFR kinase inhibitors, and pharmaceutically acceptable salts thereof.

CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF

A compound exerts a strong analgesic effect against pain, in particular, neuropathic pain and/or fibromyalgia syndrome. The cyclic amine derivative is represented by formula, a prodrug thereof or a pharmacologically acceptable salt thereof: wherein A represents a group represented by Formula (IIa), (IIb) or (IIc): wherein R3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms, R4 represents a hydrogen atom or an alkylcarbonyl group having 2 to 6 carbon atoms or an alkyl group having 1 to 6 carbon atoms and optionally substituted with an alkylcarbonylamino group having 2 to 6 carbon atoms and n represents 1 or 2, in which when R3 and R4 each independently represent an alkyl group having 1 to 6 carbon atoms, R1 represents an alkyl group having 1 to 6 carbon atoms and substituted with a hydroxyl group, an amino group or a carboxyl group.

5-CHLORO-2-DIFLUOROMETHOXYPHENYL PYRAZOLOPYRIMIDINE COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF

Compounds of Formula (00A) and methods of use as Janus kinase inhibitors are described herein.